Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis von Fox, Robert J, Coffey, Christopher S, Conwit, Robin, Cudkowicz, Merit E, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C, Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert T, Ashokkumar, Akshata, Barnes, Janel, Ecklund, Dixie, Klingner, Elizabeth, Koepp, Maxine, Long, Jeffrey D, Natarajan, Sneha, Thornell, Brenda, Yankey, Jon, Bermel, Robert A, Debbins, Josef P, Huang, Xuemei, Jagodnik, Patricia, Lowe, Mark J, Nakamura, Kunio, Narayanan, Sridar, Sakaie, Ken E, Thoomukuntla, Bhaskar, Zhou, Xiaopeng, Krieger, Stephen, Alvarez, Enrique, Apperson, Michelle, Bashir, Khurram, Cohen, Bruce A, Coyle, Patricia K, Delgado, Silvia, Dewitt, L. Dana, Flores, Angela, Giesser, Barbara S, Goldman, Myla D, Jubelt, Burk, Lava, Neil, Lynch, Sharon G, Moses, Harold, Ontaneda, Daniel, Perumal, Jai S, Racke, Michael, Repovic, Pavle, Riley, Claire S, Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Guttman, Bianca, Yadav, Vijayshree, Zabeti, Aram

Volltext

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression von Alban, Tyler J, Bayik, Defne, Otvos, Balint, Rabljenovic, Anja, Leng, Lin, Jia-Shiun, Leu, Roversi, Gustavo, Lauko, Adam, Momin, Arbaz A, Mohammadi, Alireza M, Peereboom, David M, Ahluwalia, Manmeet S, Matsuda, Kazuko, Yun, Kyuson, Bucala, Richard, Vogelbaum, Michael A, Lathia, Justin D

Volltext

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF) von Ha, Wendy, Sevim-Nalkiran, Hatice, Zaman, Ashraf M., Matsuda, Kazuko, Khasraw, Mustafa, Nowak, Anna K., Chung, Liping, Baxter, Robert C., McDonald, Kerrie L.

Volltext

MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design von Oskarsson, Björn, Maragakis, Nicholas, Bedlack, Richard S, Goyal, Namita, Meyer, Jenny A, Genge, Angela, Bodkin, Cynthia, Maiser, Samuel, Staff, Nathan, Zinman, Lorne, Olney, Nicholas, Turnbull, John, Brooks, Benjamin Rix, Klonowski, Emelia, Makhay, Malath, Yasui, Seiichi, Matsuda, Kazuko

Volltext

Albuterol Administration Is Commonly Associated With Increases in Serum Lactate in Patients With Asthma Treated for Acute Exacerbation of Asthma von Lewis, Lawrence M., MD, Ferguson, Ian, BA, House, Stacey L., MD, PhD, Aubuchon, Kristen, Schneider, John, BA, Johnson, Kirk, PhD, Matsuda, Kazuko, MD, PhD

Volltext

Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial von Babu, Suma, Hightower, Baileigh G., Chan, James, Zürcher, Nicole R., Kivisäkk, Pia, Tseng, Chieh-En J., Sanders, Danica L., Robichaud, Ashley, Banno, Haruhiko, Evora, Armineuza, Ashokkumar, Akshata, Pothier, Lindsay, Paganoni, Sabrina, Chew, Sheena, Dojillo, Joanna, Matsuda, Kazuko, Gudesblatt, Mark, Berry, James D., Cudkowicz, Merit E., Hooker, Jacob M, Atassi, Nazem

Volltext

Study protocol to evaluate MN-001’s (tipelukast) efficacy, safety and tolerability in subjects with non-alcoholic fatty liver disease (NAFLD), hypertriglyceridemia (HTG) and type-2... von Matsuda, Kazuko, Makhay-Bozym, Malath, Iwaki, Yuichi

Volltext

Bacterial Identification by 16S rRNA Gene PCR-Hybridization as a Supplement to Negative Culture Results von MATSUDA, Kazuko, IWAKI, Kosuke K, GARCIA-GOMEZ, Jean, HOFFMAN, Jill, INDERLIED, Clark B, MASON, Wilbert H, IWAKI, Yuichi

Volltext

MN-002, The metabolite of MN-001 (tipelukast) promotes macrophage cholesterol efflux von Huicheng, Qi, Ogura, Ogura Masatsune, Kazuko, Matsuda, Hajime, Okuyama, Iwaki, Yuichi

Volltext

DDDR-25. IBUDILAST AND ANTI-PD-L1 COMBINATION TREATMENT SIGNIFICANTLY IMPROVES SURVIVAL IN A SEX-DEPENDENT MANNER IN A MURINE MODEL OF GLIOBLASTOMA von Jarmula, Jakub, Lee, Juyeun, Kurlich, Andrew, Matsuda, Kazuko, Bayik, Defne, Lathia, Justin

Volltext

COMBAT-ALS Phase 2b/3 Trial of MN-166 (Ibudilast) in ALS: Study Design and Trial Update (5149) von Oskarsson, Bjorn, Dojillo, Joanna, Makhay, Malath, Matsuda, Kazuko

Volltext

Development of a real-time quantitative PCR assay for detection of a stable genomic region of BK virus von Iwaki, Kosuke K, Qazi, Suhail H, Garcia-Gomez, Jean, Zeng, Deanna, Matsuda, Yasuhiro, Matsuda, Kazuko, Martinez, Monica E, Toyoda, Mieko, Kore, Arputharaj, Stevens, Wesley T, Smogorzewski, Miroslaw, Iwaki, Daisuke D, Qazi, Yasir, Iwaki, Yuichi

Volltext

CTIM-36. IMMUNOHISTOCHEMISTRY EVALUATION ON PRE-TREATMENT TUMOR TISSUE PREDICTS TREATMENT RESPONSE TO MN-166 (IBUDILAST) AND TEMOZOLOMIDE COMBINATION THERAPY IN GLIOBLASTOMA PATIEN... von Lathia, Justin, Lauko, Adam, Matsuda, Kazuko, Makhay, Malath, Nayak, Lakshmi, Chukwueke, Ugonma, Lee, Eudocia, Reardon, David, Beroukhim, Rameen, Batchelor, Tracy, Aquilanti, Elisa, Wen, Patrick

Volltext

Effect of treating glioblastoma with a cytokine inhibitor, ibudilast, in combination with temozolomide on survival in a patient-derived xenograft model von McDonald, Kerrie Leanne, Ha, Wendy, Sevim, Hatice, Matsuda, Kazuko, Khasraw, Mustafa

Volltext

Effect of ibudilast on macular measures in progressive MS: OCT analysis from a phase II trial (P3.2-049) von Bermel, Robert, Barnes, Janel, Yankey, Jon, Klingner, Elizabeth, Natarajan, Sneha, Coffey, Christopher, Goodman, Andrew, Klawiter, Eric, Matsuda, Kazuko, Naismith, Robert, Fox, Robert

Volltext

Effect of Ibudilast on Neurofilament-light Chain in Progressive MS: Analysis from a Phase II Trial (P3.2-033) von Fox, Robert, Karafa, Matthew, Konig, Victoria, Natarajan, Natarajan, Barro, Christian, Bermel, Robert, Coffey, Christopher, Goodman, Andrew, Klawiter, Eric, Matsuda, Kazuko, Naismith, Robert, Kuhle, Jens

Volltext

Response to Treatment According to Progressive Disease Type: Analysis from a Phase II Progressive MS Trial of Ibudilast (S12.007) von Goodman, Andrew, Barnes, Janel, Yankey, Jon, Klingner, Elizabeth, Natarajan, Sneha, Bermel, Robert, Coffey, Christopher, Klawiter, Eric, Matsuda, Kazuko, Naismith, Robert, Fox, Robert

Volltext

A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis (CT.004) von Fox, Robert, Ashokkumar, Akshata, Barnes, Janel, Chase, Marianne, Coffey, Christopher, Conwit, Robin, Cudkowicz, Merit, Ecklund, Dixie, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric, Klinger, Elizabeth, Koepp, Maxine, Matsuda, Kazuko, McGovern, Michelle, Naismith, Robert, Yankey, Jon

Volltext

IBUDILAST FOR USE IN THE TREATMENT OF POST-COVID CONDITIONS von MATSUDA, Kazuko

Volltext bestellen

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis von Fox, Robert J, Coffey, Christopher S, Cudkowicz, Merit E, Gleason, Trevis, Goodman, Andrew, Klawiter, Eric C, Matsuda, Kazuko, McGovern, Michelle, Conwit, Robin, Naismyth, Robert, Ashokkumar, Akshata, Bermel, Robert, Ecklund, Dixie, Koepp, Maxine, Long, Jeffrey, Natarajan, Sneha, Ramachandran, Srividya, Skaramagas, Thomai, Thornell, Brenda, Yankey, Jon, Agius, Mark, Bashir, Khurram, Cohen, Bruce, Coyle, Patricia, Delgado, Silvia, Dewitt, Dana, Flores, Angela, Giesser, Barbara, Goldman, Myla, Jubelt, Burk, Lava, Neil, Lynch, Sharon, Miravalle, Augusto, Moses, Harold, Ontaneda, Daniel, Perumal, Jai, Racke, Michael, Repovic, Pavle, Riley, Claire, Severson, Christopher, Shinnar, Shlomo, Suski, Valerie, Weinstock-Gutman, Bianca, Yadav, Vijayshree, Zabeti, Aram

Volltext